Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | Oxalyl chloride | HCID 65578 | — |
| Reactant | Sodium Bicarbonate | HCID 516892 | — |
| Reactant | 3,5-Bis(difluoromethyl)-1H-pyrazole-1-acetic acid | HCID 1229844 | — |
| Reactant | HCID 86719955 | HCID 86719955 | — |
| Catalyst | Dimethylformamide | HCID 6228 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 86719954 | HCID 86719954 | — |
Reaction Steps
To a solution of [3,5-bis-(difluoromethyl)-1H-pyrazol-1-yl]acetic acid (2 g) in dichloromethane (40 ml) are added, at 0° C., oxalyl chloride (3.273 g) and one drop of N,N-dimethylformamide. The reaction mixture is stirred at room temperature for 2 hours. The solvent and the excess reagent are removed under reduced pressure. The solid residue is again dissolved in dichloromethane (15 ml) and, at 0° C., added dropwise to a solution of 4-{4-[5-(2,6-difluoro-3-hydroxyphenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidinium chloride (compound A) and triethylamine (5.0 eq.) in dichloromethane (100 ml). The reaction mixture is stirred at room temperature overnight. Then it is admixed with concentrated sodium hydrogencarbonate solution, and the aqueous phase is removed and extracted with ethyl acetate. The combined organic phases are dried over sodium sulphate and concentrated. Purification by column chromatography gives 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-(4-{4-[5-(2,6-difluoro-3-hydroxyphenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)ethanone (1.818 g).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09144238B2 |
|---|
| Source dataset | uspto-grants-2015_09 |
|---|
| ORD ID | ord-1deca8c6e9b744f5b1cc081290ff72dd |
|---|
| Source note | uspto-grants-2015_09 |
|---|